You are being asked to take part in a research study of an experimental treatment called
sotatercept. “Experimental” means that sotatercept is currently being tested and is not
approved for sale by any Health Authorities/regulatory agencies, such as the Food and Drug
Administration (FDA), in any country.
We want to find out if taking sotatercept with your current medications is safe and can help
slow the progression of Pulmonary Hypertension caused by left heart disease compared with your current
medications alone.